Cerevel Therapeutics Hldg Inc
(CERE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -131,912 | -432,842 | -300,182 | -203,821 | -104,286 |
| Depreciation Amortization | -4,585 | -14,073 | -10,052 | -7,003 | -3,885 |
| Accounts payable and accrued liabilities | -1,194 | 2,038 | 1,759 | -737 | -2,768 |
| Other Working Capital | -5,179 | 16,113 | 7,592 | -9,739 | -10,618 |
| Other Operating Activity | 23,201 | 86,463 | 56,002 | 49,050 | 26,634 |
| Operating Cash Flow | $-119,669 | $-342,301 | $-244,881 | $-172,250 | $-94,923 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,436 | 77,530 | 226,836 | 174,929 | 111,119 |
| PPE Investments | -271 | -3,808 | -2,906 | -2,393 | -336 |
| Investing Cash Flow | $19,165 | $73,722 | $223,930 | $172,536 | $110,783 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 15,625 | N/A | N/A |
| Common Stock Issued | 4,550 | 517,505 | 9,133 | 7,938 | 1,574 |
| Other Financing Activity | -75 | 31,111 | 15,486 | 31,111 | -139 |
| Financing Cash Flow | $4,475 | $548,616 | $40,244 | $39,049 | $1,435 |
| Beginning Cash Position | 418,425 | 138,388 | 138,388 | 138,388 | 138,388 |
| End Cash Position | 322,396 | 418,425 | 157,681 | 177,723 | 155,683 |
| Net Cash Flow | $-96,029 | $280,037 | $19,293 | $39,335 | $17,295 |
| Free Cash Flow | |||||
| Operating Cash Flow | -119,669 | -342,301 | -244,881 | -172,250 | -94,923 |
| Capital Expenditure | -271 | -3,808 | -2,906 | -2,393 | -336 |
| Free Cash Flow | -119,940 | -346,109 | -247,787 | -174,643 | -95,259 |